Drug discovery strategies: technologies to accelerate translation from target to drug (Q36028608)

11 August 2017

1 reference

title

Drug discovery strategies: technologies to accelerate translation from target to drug (English)

1 reference

11 August 2017

1 reference

P Workman

1

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

11 August 2017

published in

Journal of Chemotherapy

1 reference

11 August 2017

volume

16 Suppl 4

1 reference

11 August 2017

page(s)

13-15

1 reference

Discovering novel chemotherapeutic drugs for the third millennium

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

The impact of genomic and proteomic technologies on the development of new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

Finding the needle in the haystack: why high-throughput screening is good for your health

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

HSP90 as a new therapeutic target for cancer therapy: the story unfolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

Histone modification enzymes: novel targets for cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.13

10.1179/JOC.2004.16.SUPPLEMENT-1.13

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference